Literature DB >> 15538755

The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.

Eva-Maria Schneider1, Emina Torlakovic, Albert Stühler, Volker Diehl, Hans Tesch, Bernd Giebel.   

Abstract

Hodgkin/Reed-Sternberg (HRS) cells of classical Hodgkin's lymphoma (cHL) are thought to be derived from germinal centre B-cells in almost all cases. However, expression profiling has revealed that HRS cells do not show a germinal centre B-cell-like phenotype. Although the nature of this aberrant phenotype and the underlying molecular mechanisms remain largely unknown, it has been reported that the activity of NOTCH1 plays an important role in the growth and survival of HRS cells. In some leukaemic cell lines, the effect of Notch signalling is mediated by the early transcription factor GATA-2. This and the fact that HRS cells lack expression of PU.1, which can repress Gata-2, led to an investigation of GATA-2 expression in HRS cells. GATA-2 expression was found in all the cHL-derived cell lines studied, but not in a Burkitt lymphoma-derived cell line. In addition, 50% of biopsies from patients with cHL contained GATA-2-expressing HRS cells. In contrast, neither normal germinal centre B-cells nor malignant cells of nodular lymphocyte-predominant Hodgkin's lymphoma, Burkitt lymphoma or diffuse large B-cell lymphoma expressed GATA-2. Thus, GATA-2 expression was found specifically in HRS cells of cHL, suggesting that GATA-2 is important in establishing the abnormal B-cell phenotype of HRS cells. Copyright (c) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538755     DOI: 10.1002/path.1664

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

Authors:  Jeffrey I Cohen; Lesia Dropulic; Amy P Hsu; Christa S Zerbe; Tammy Krogmann; Kennichi Dowdell; Ronald L Hornung; Jana Lovell; Nancy Hardy; Dennis Hickstein; Edward W Cowen; Katherine R Calvo; Stefania Pittaluga; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-05-11       Impact factor: 9.079

2.  Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.

Authors:  Elena Cubedo; Andrew J Gentles; Chuanxin Huang; Yasodha Natkunam; Shruti Bhatt; Xiaoqing Lu; Xiaoyu Jiang; Isabel Romero-Camarero; Aharon Freud; Shuchun Zhao; Carlos E Bacchi; Jose A Martínez-Climent; Isidro Sánchez-García; Ari Melnick; Izidore S Lossos
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

3.  Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.

Authors:  Olga Bohn; Takahiro Maeda; Alexander Filatov; Andrea Lunardi; Pier Paolo Pandolfi; Julie Teruya-Feldstein
Journal:  Int J Surg Pathol       Date:  2013-12-10       Impact factor: 1.271

Review 4.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

5.  Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.

Authors:  Stefan Nagel; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  Oncotarget       Date:  2015-11-24

6.  Decreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinoma.

Authors:  Yi-Wei Li; Jia-Xing Wang; Xin Yin; Shuang-Jian Qiu; Han Wu; Rui Liao; Yong Yi; Yong-Sheng Xiao; Jian Zhou; Bo-Heng Zhang; Jia Fan
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.